Journals / Genel Tıp Dergisi / 2006 / Cilt: 16 - Sayı: 3

A global view to inflammatory mediators

İnflamatuar medyatörlere toplu bir bakış

Pages
143–152
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, increased inflammatory response results in complications included hypersensitivity and postinflammatory reactions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this review, it has been given information about chemical mediators of inflammations such as vasoactive amines, plasma proteases, arachidonic acid metabolites, leukocyte products, trombocyte activating factor, cytokines, growth factors, nitric oxide, substance P, calpains, hem oxigenases, high mobility grup box-1 protein.
📊
Key Findings & Data:Main Findings: Vascular and cellular responses of inflammation arise from chemical mediators, which can be released by plasma cells through an inflammatory stimulus.
💡
Conclusion & Impact:However, increased inflammatory response results in complications included hypersensitivity and postinflammatory reactions.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Nitrik oksit · Kalpain · Araşidonik asit

Abstract

Objective: In this review, it has been given information about chemical mediators of inflammations such as vasoactive amines, plasma proteases, arachidonic acid metabolites, leukocyte products, trombocyte activating factor, cytokines, growth factors, nitric oxide, substance P, calpains, hem oxigenases, high mobility grup box-1 protein. Main Findings: Vascular and cellular responses of inflammation arise from chemical mediators, which can be released by plasma cells through an inflammatory stimulus. Acute and chronic inflammatory response symptoms such as pain, fever, edema, rubor, function leasing and scar formation repair by removing necrotic cells and tissues resulted from the damaged cell and, therefore limit the incident. Conclusion: Human being does not live long without these defense mechanism of inflammation. Adversely, infections are going to reduce, but in addition to, burns not heal, wounds be opened, painful and be supurative. However, increased inflammatory response results in complications included hypersensitivity and postinflammatory reactions.

Özet

Amaç: Bu derlemede inflamasyonun kimyasal medyatörleri olan vazoaktif aminler, plazma proteazları, araşidonik asid metabolitleri, lökosit ürünleri, trombosit aktive edici faktör, sitokinler, büyüme faktörleri, nitrik oksid ve son yıllarda üzerinde çalışılan yeni medyatörler olan P maddesi, kalpainler, hem oksigenaz-1 ve yüksek göçlü grup-1 protein hakkında bilgi verilecektir. Ana Bulgular: İnflamasyonun vasküler ve hücresel yanıtları, plazma hücrelerinden çıkan ve inflamatuar bir uyaranla meydana gelen kimyasal faktörlerle ortaya çıkmaktadır. Ağrı, ateş, ödem, kızarıklık, fonksiyon kaybı ve skar oluşumu gibi akut ve kronik inflamatuar yanıt belirtileri, organizmayı hücre incinmesine neden olan etkenlerden ve buna bağlı oluşan nekrotik hücre ve dokulardan temizleyerek tamir eder ve olayı sınırlar. Sonuç: Kimyasal medyatörlerin aracılık ettiği inflamasyonun koruyucu yanıtları olmaksızın yaşam sürdürülemez. Aksi takdirde, infeksiyonlar azalacak, yanıklar iyileşmeyecek, yaralar açık ve ağrılı olacaktır. Bununla birlikte, artmış inflamatuar yanıt, aşırı duyarlılık ve postinflamatuar reaksiyonlarla komplikasyonlara neden olabilir.

🔖

Cite This Article

KURALAY, F., ÇAVDAR, Z. (2006). A global view to inflammatory mediators. Genel Tıp Dergisi, Cilt: 16 - Sayı: 3, 143–152. https://ajindex.com/articles/224961

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (21)

  1. Çevikbaş U. Temel Patoloji. Nobel Tıp Kitabevi, İstanbul; 1995:25-60
  2. Mullington JM, Hinze-Selch D, Pollmavher T. Mediators of inflammation. Ann N Y Acad Sci 2001;933: 201-10
  3. Aghabeigi B. The pathophysiology of the pain. Br Dent J 1992;173:91 - 7
  4. Sessle BJ. New insights into peripheral chemical mediators of pain and inflammation. J Orofac Pain 2001;15:1-5
  5. Sies H. Strategies of antioxidant defense. Eur J Biochemistry 1993;215:213-9
  6. Bienvenu J. Exploration of cytokines in biological fluids. CR Seances Soc Biol Fil 1995;189:545-55
  7. Takabayashi T, Vannier E, Clark BD. A new biologic role for C 3a and C3a des Arg: Regulation of TNF-a and IL-1 ß synthesis. J Immunol 1996;156:570 - 83
  8. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. British Med Bulletin 1993;49:481-93
  9. Haeggstrom JZ, Kull F, Rudberg PC, Tholander F, Thunnissen MM. Leukotriene A4 hydrolase. Prostaglandins Other Lipid Mediat 2002;68:495-510
  10. Park EJ, Barbul A Understanding the role of immune regulation in wound healing. American J Surgery 2004;187: 11S-6S
  11. Drenth JP, Van Uum SH, Van Deuren M. Endurance run increased circulating IL-6 and IL-1 ra but down-regulates ex vivo TNF-a and IL-1 ß production. J Appl Physiol 1995;79:1497-503
  12. Armstrong L, Jordan N, Millar A. Interleukin 10 regulation of TNF-a from human alveolar macrophages and pheripheral blood monocytes. Thorax 1996;51:143-9
  13. Gardner RV, McKinnon E, Poretta C, Leiva L. Hemopoietic function after use of IL-1 with chemotherapy or irradition. J Immunol 2003;171:1202-6
  14. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002;20:1S-13S
  15. Witowski J, Ksiazek K, Jorres A. Interleukin-17: A mediator of inflammatory responses. Cell Mol Life Sci 2004;61:567-79
  16. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21:467-76
  17. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY. Evidence for early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002;197:322-32
  18. Rizk M, Witte M, Barbul A. Nitric Oxide and Wound Healing. World J Surg 2004;28:301-6
  19. Coleman JW. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol 2002;129:4-10
  20. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes BJ. Increased nitric oxide in exhaled air of asthmatics. Lancet 1994;343:133-5
  21. Robbins RA, Barnes PJ, Springall DR.